Pharm ChemistryAnti-tumor Activity of N4 [(E)-1-(2-hydroxyphenyl) Methylidene], N4-[(E)-2-Phenylethylidene], N4 [(E,2E)-3-Phenyl-2-propenylidene], and N4[(E)ethylidene] Isonicotinohydrazide on K562 and Jurkat Cell Lines

Add time:09/03/2019    Source:sciencedirect.com

ABSTRACTUsing the water eliminated mechanism, reactions of 4-pyridinecarboxylic acid hydrazide and salicylaldehyde, benzaldehyde, cinnamaldehyde, and formaldehyde afforded the corresponding N4[(E)-1-(2-hydroxyphenyl) methylidene] (NHPM), N4-[(E)-2-phenylethylidene] (NPI), N4[(E,2E)-3-phenyl-2-propenylidene] (NPPI), and N4[(E) ethylidene] (NEI) isonicotinohydrazide, in high yields, after several minutes, as reported. These new compounds have shown antitumor activity against two kinds of cancer cells, which are K562 (human chronic myeloid leukemia) and Jurkat (human T lymphocyte carcinoma).

We also recommend Trading Suppliers and Manufacturers of (2E)-3-(2-hydroxyphenyl)-1-pyridin-3-ylprop-2-en-1-one (cas 18455-64-6). Pls Click Website Link as below: cas 18455-64-6 suppliers

Prev:Luminescence studies on physostigmine, rubreserine (cas 18455-27-1) and adrenochrome
Next:5-Aryl-2-(2-hydroxyphenyl)furan-3-carbaldehyde: synthesis and study on its ring-chain tautomerism)